Matches in Nanopublications for { ?s ?p "[We analyzed the sera from patients with vitiligo and cutaneous melanoma for reactivity toward tyrosinase peptide sequences 1) endowed with low level of similarity to human proteome, and 2) potentially able to bind HLA-DR1 Ags.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP762951.RAqHQXW1_OfkKg5oZBuF9PzP6FaiB6RGs6FpMhQDozFck130_assertion description "[We analyzed the sera from patients with vitiligo and cutaneous melanoma for reactivity toward tyrosinase peptide sequences 1) endowed with low level of similarity to human proteome, and 2) potentially able to bind HLA-DR1 Ags.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP762951.RAqHQXW1_OfkKg5oZBuF9PzP6FaiB6RGs6FpMhQDozFck130_provenance.
- NP174423.RAyV2dpbj5FViYuSiurDjbav8miYU9Rs1RW2FMfbfobPE130_assertion description "[We analyzed the sera from patients with vitiligo and cutaneous melanoma for reactivity toward tyrosinase peptide sequences 1) endowed with low level of similarity to human proteome, and 2) potentially able to bind HLA-DR1 Ags.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP174423.RAyV2dpbj5FViYuSiurDjbav8miYU9Rs1RW2FMfbfobPE130_provenance.
- NP935214.RA1IWYik3b7jU_7syLch-y_UDPNHjTyvLESRUul8fRAMs130_assertion description "[We analyzed the sera from patients with vitiligo and cutaneous melanoma for reactivity toward tyrosinase peptide sequences 1) endowed with low level of similarity to human proteome, and 2) potentially able to bind HLA-DR1 Ags.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP935214.RA1IWYik3b7jU_7syLch-y_UDPNHjTyvLESRUul8fRAMs130_provenance.
- assertion description "[We analyzed the sera from patients with vitiligo and cutaneous melanoma for reactivity toward tyrosinase peptide sequences 1) endowed with low level of similarity to human proteome, and 2) potentially able to bind HLA-DR1 Ags.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP763994.RA1dUBkiVgw-kRsEPWah7RuKAWs2Z3IMFiQtUa0MDoIF8130_assertion description "[We analyzed the sera from patients with vitiligo and cutaneous melanoma for reactivity toward tyrosinase peptide sequences 1) endowed with low level of similarity to human proteome, and 2) potentially able to bind HLA-DR1 Ags.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP763994.RA1dUBkiVgw-kRsEPWah7RuKAWs2Z3IMFiQtUa0MDoIF8130_provenance.
- NP521288.RA4sKl6LfSSNtlmZuJDvGjLToGpLhe6NSdxMm2UD7Tiqo130_assertion description "[We analyzed the sera from patients with vitiligo and cutaneous melanoma for reactivity toward tyrosinase peptide sequences 1) endowed with low level of similarity to human proteome, and 2) potentially able to bind HLA-DR1 Ags.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP521288.RA4sKl6LfSSNtlmZuJDvGjLToGpLhe6NSdxMm2UD7Tiqo130_provenance.